NCT02212912 (GoldenBridge) is a NA clinical trial of improvement intervention in Ischemic Stroke, sponsored by Beijing Tiantan Hospital.

Who is sponsoring NCT02212912?

NCT02212912 is sponsored by Beijing Tiantan Hospital.

What drugs are being tested in NCT02212912?

Interventions in NCT02212912: improvement intervention, no intervention.

What condition does NCT02212912 study?

NCT02212912 studies Ischemic Stroke.

Is NCT02212912 still recruiting?

NCT02212912 is currently completed. Last updated 13 July 2020.

Last reviewed 2020-07-13 · How we verify

NCT02212912: GoldenBridge

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Intervention to Bridge the Evidence-based Gap in Stroke Care Quality

Completed NA Last updated 13 July 2020

What this trial tests

NA trial testing improvement intervention in Ischemic Stroke in 4,800 participants. Completed in 30 July 2016.

Timeline

10 August 2014

Primary endpoint
20 June 2015

30 July 2016

Quick facts

Lead sponsor	Beijing Tiantan Hospital
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	4,800
Start date	10 August 2014
Primary completion	20 June 2015
Estimated completion	30 July 2016
Sites	1 location across China

Drugs / interventions tested

improvement intervention
no intervention

Conditions studied

Ischemic Stroke — all drugs for Ischemic Stroke →

Sponsor

Beijing Tiantan Hospital

Who can join

18 and older, any sex, with Ischemic Stroke. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to evaluate whether a multifaceted quality improvement intervention can improve the adherent rate of individual and composite of evidence-based performance measures for patients with acute ischemic stroke within the first 7 days of symptom onset and reduce the incidence of a new clinical vascular event, disability, and all-cause mortality at discharge and long term clinical outcome.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

Organised inpatient (stroke unit) care for stroke: network meta-analysis.
Langhorne P, Ramachandra S, Stroke Unit Trialists' Collaboration. · · 2020 · cited 182× · PMID 32324916 · DOI 10.1002/14651858.cd000197.pub4
Effect of a Multifaceted Quality Improvement Intervention on Hospital Personnel Adherence to Performance Measures in Patients With Acute Ischemic Stroke in China: A Randomized Clinical Trial.
Wang Y, Li Z, Zhao X, Wang C, et al · · 2018 · cited 82× · PMID 29959443 · DOI 10.1001/jama.2018.8802
Interventions for the uptake of evidence-based recommendations in acute stroke settings.
Lynch EA, Bulto LN, Cheng H, Craig L, et al · · 2023 · cited 12× · PMID 37565934 · DOI 10.1002/14651858.cd012520.pub2

Verify or expand the search:

Other recruiting trials for Ischemic Stroke

Currently open trials in the same condition.

NCT07509645 — Efficacy and Safety of Interleukin-6 Receptor Inhibitor Combined With Endovascular Treatment in Patients With Acute Post · Phase 3 · recruiting
NCT07375953 — Repeated Intravenous Thrombolysis for Ischemic Stroke Within 3.0 Hours of Onset With Tenecteplase (RITIS-TNK) · Phase 2 · recruiting
NCT07375966 — Repeated Intravenous Thrombolysis for Ischemic Stroke With Medium to Large Vessel Occlusion Presenting Within 4.5 Hours · Phase 2 · recruiting
NCT07491952 — Continuous Dual Aspiration Technique With Zoom System for Stroke · recruiting
NCT07371455 — A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LWP779 in Healthy Participants · Phase 1 · recruiting

Other Beijing Tiantan Hospital trials

Trials by the same sponsor.

NCT07341854 — Dexamethasone Palmitate for Postoperative Pain · NA · not yet recruiting
NCT07527013 — Stratified Blood Pressure Management Strategy After Endovascular Treatment for Acute Ischemic Stroke · Phase 3 · not yet recruiting
NCT07520370 — Effect of Perioperative Ulinastatin on Postoperative Stroke in Patients With Brain Tumor · NA · not yet recruiting
NCT07526987 — Efficacy and Safety of Minocycline in Patients With Acute Ischaemic Stroke Receiving Intravenous Thrombolysis · Phase 3 · not yet recruiting
NCT07591207 — The Efficacy and Safety of Loxoprofen Sodium Patch in Relieving Postoperative Pain After Laparoscopic Surgery · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02212912 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Beijing Tiantan Hospital
Last refreshed: 13 July 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02212912.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing